SST has developed and continues to develop products to combat the increasing losses being incurred by airlines and a broad range of transport sectors due to theft and fraud. We have already produced an overview video for the company, used prominently on their website, and they have now just commissioned Good Call Media to produce a product explainer video designed to be shown to potential investors in the company:
We have worked with XP Power for a number of years, starting with ‘as live’ interviews with senior directors highlighting their bi-annual financial results.
The company wanted to take our involvement a step further. As part of their move to attract the very best candidates to work with their teams, Good Call Media co-owner, Fiona Molloy, was asked to record a number of interviews with key employees and the results were used on social media, including her own Linked In site.
Working with our partners, worldwide veterinary health company, Ceva Animal Health, we have been highlighting fascinating new research into the attachment theory between children and young people and their companion animals.
Many experts agree that companion animals can be beneficial to human wellbeing, and there is considerable anecdotal evidence to support this idea. High-quality, peer-reviewed science in this area is, however, largely lacking. This makes it difficult to develop effective evidence-based policies, best 
practices and guidelines for organisations and individuals working in the field of animal-assisted interventions.
Sound policies and guidance are vital to ensure animal-assisted interventions – ranging from fully-trained assistance animals to family pets – respect the well-being of both humans and animals, and
deliver maximum benefits. A sound evidence base is also crucial if public health agencies and other organisations are to be convinced to allocate scarce resources to animal-assisted interventions over other options.
As part of its ongoing support to the International Association of Human-Animal Interaction Organizations (IAHAIO), Ceva is continuing to support innovative research to help enhance the science around the human-animal bond. It particularly focuses on how pets can improve the wellbeing 
of children and young people, including those living with mental health challenges. Earlier support from Ceva helped to shed light on a mechanism (synchrony 1) that may underlie the effect of dog-assisted therapy and how this makes a difference for children with autism spectrum disorder and Down syndrome 2.
The latest PhD researcher to be supported by Ceva is Danielle Groenewoud, an experienced clinical psychologist, who is comparing the nature of the bond between youngsters aged 8-14 years with their pets and also with their parents. In her clinical work with adolescents with depression or anxiety, Danielle is used to working with the whole family – parents and siblings, and often pets too. She realised, however, that 20-years ago, when she trained, there was nothing in the curriculum about the human animal bond and, even now, this topic receives only scant coverage.
Our New York Stock Exchange-quoted client, Volition RX, has mastered the art of making company announcements…using video.
You can see a prime example of a key announcement from Volition Veterinary by clicking here.
Heska’s Nu.Q® Canine Cancer Screen and Monitor Test will operate on Heska’s proprietary Element i+® Immunodiagnostic Analyzer, a point-of-care platform which provides veterinarians with rapid, accurate, low cost, and easy-to-use on-site testing in the veterinary clinic, to support clinical decision-making and improve patient outcomes.
Dr. Tom Butera, Chief Executive Officer of Volition Veterinary Diagnostics Development LLC, said: 
“This is a breakthrough moment for Volition: it is the first time the Nu.Q® platform is available outside of centralised laboratory testing. Our mission at Volition is to ensure that our Nucleosomics™ technology is accessible and affordable worldwide, to detect and monitor disease earlier and improve outcomes. We are delighted to be working with Heska and their remarkable point-of-care technology to enable vets, pets, and pet families to benefit from our innovative technology. We are thrilled to advance towards full commercial launch and license payment milestones.”
Kevin Wilson, Heska’s Chief Executive Officer and President said, “We are pleased now to offer our transformative Nu.Q® Canine Cancer Screen and Monitor Test at the point-of-care, which we believe 
will revolutionize canine cancer patient management. Available now for pre-order, the screen and monitoring test will assist veterinarians to detect cancer early, in the clinic, in minutes, and for under $50, to support clinical decision-making during annual check-ups, regular wellness exams, healthcare interventions, treatment cycles, and remission. While we also offer this technology at the central reference lab, we believe the benefits of point-of-care cancer screening and monitoring are significant and will provide outsized benefits to veterinarians, nursing and technical teams, pets, and pet families.”
“With this forthcoming launch, millions of pets will have access to critical cancer screening and monitoring in the clinic, to catch, treat and drive recovery from cancers earlier, for better healthcare outcomes and peace of mind. We believe that this innovation will be transformative to veterinarian healthcare as Heska begins to roll it out exclusively to the point-of-care, with our global commercial launch targeted for early in the second quarter of this year,” concluded Mr. Wilson.
Volition is developing simple, easy-to-use, cost-effective blood tests to help diagnose and monitor a range of life-altering diseases including cancer in both humans and animals. For more information about Volition’s Nu.Q® technology go to: www.volition.com
His work in Australia resulted in an invitation to our co-owner, Nik Wood, to meet Australia’s Governor General, at Government House in capital Canberra, together with a very special group of dogs!
Nik prepares to meet with the Governor General of Australia at Government House, Canberra
Nik met with His Excellency General the Honourable David Hurley and Her Excellency, Linda Hurley, as part of a group from Integra Service Dogs Australia.
In recent years, we have highlighted the amazing work of 
Assistance Dogs Australia through our major client, Ceva Animal Health and the President of Assistance Dogs International, Richard Lord who is now National Partnerships Manager with Integra, the organisation that provides service dogs for military veterans and first responders who encounter post traumatic stress syndrome (PTSD) as a result of their role.
Integra is a Not-for-Profit Organisation, founded by Veterans for supporting Veterans and First Responders suffering from PTSD. Integra specialises in the sourcing, matching, placement, ongoing training and development of high quality Labrador trainee Service Dogs with Veterans and First Responders suffering from PTSD.
They are a national provider, delivering Assistance Dog services in most states and territories, and have efficiently matched and placed more than one hundred (100) high quality Labrador dogs with veterans and first responders.
See the associated video report here:
Integra was founded in 2016 to deliver the vision established by Mr Ken Lloyd, OAM MSs JP (NSW), which is to provide excellent Service Dogs to Veterans and First Responders who have served our country. Learn more about Integra in the video below.
We have had another great posting on Linked In from one of our innovative clients.
SRE is one of the UK’s leading sustainability consultancies.
The company is highly respected within the construction and renewable energy industries. Over 80% of its work is for return clients and they wanted to show the strength of their team through a video “Building for the Future”, which was filmed and edited by Good Call Media co-owner, Fiona Molloy.
It prompted this Linked In post from client, Anna Maclean – thanks Anna.
When Security Seal Technology wanted to explain their brand new product to the aviation industry,they chose Good Call Media to create a ‘video explainer’.
Security Seal Technology Ltd is the first to explore and develop fully electronic auditable track and trace security for the airline, road, rail and retail sectors. From the research and development of the products to the cloud-based SAFTA Management Portal that’s been developed to capture and report on the data recorded from the electronic locks. Security Seal Technology now offers an alternative in the electronic sealing of goods and assets.
SAFTA is the culmination of professional development, industry research and airline trials resulting in a high security sealing device to secure in-flight carts and canisters.
For the last thirty years in-flight equipment has been principally secured by single use plastic seals and locked by ineffective padlocks which offered little deterrent to thieves. It is estimated by IATA that losses in excess of $50m per year from duty free and retail theft is extremely conservative.
The threat from international terrorism is ever present and the detection of unauthorised packages
being inserted in carts and canisters is a major concern for airline security and law enforcement agencies.
The need for a security device to alert against such occurrences was high on the list of requirements when Security Seal Technology engineers were commissioned to minimise the risks associated with theft and terrorist attack.
Security Seal Technology studied aviation logistics systems and it was clear that there was a requirement for the development of a high security seal which could identify individual staff, record all operations and ensure set procedures were followed.
Due to the investment in existing galley stock it was also evident that the new seal had to be designed in such a manner that it could retrofit onto most carts and canisters currently in circulation, irrespective of the manufacturer or supplier of those assets.
We produced the dynamic video to announce the new World Veterinary Association’s (WVA) Global Veterinary Awards in partnership with our major client, Ceva Animal Health.
Our video (see below) was shown at the WVA’s annual Congress in Taipei, Taiwan.
Veterinary professionals play a critical role in protecting the welfare of animals and it was therefore
logical that the awards be extended to include the 4 strategic objectives of WVA.
In total, the new WVA Global Veterinary Awards comprise 6 awards that will recognise veterinarians for their work in providing animal owners, governments, health authorities, farmers, other veterinarians, and the public with best practice across:
WVA calls out to its members around the world for nominations, which will be assessed by the working group of each of the WVA Strategic Objectives. The award winners will be announced in early 2024 with a final ceremony during WVAC 2024 in Cape Town, South Africa.
Speaking on behalf of WVA, President, Dr. Rafael Laguens said, “With these awards, the WVA, as the voice of the global veterinary profession, wants to recognize the work of veterinarians worldwide, who, in their daily lives, have provided outstanding and exemplary services for the benefit of their societies. Highlighting also the unique role veterinarians play in protecting the health and welfare of animals, humans, and the environment.”
For Ceva Santé Animale, Chairman & CEO Dr. Marc Prikazsky added, “As a veterinarian, the creation of these Awards and their success to date, give me immense pride when I see the scope and impact of the work carried out by my fellow professionals. We are therefore delighted to continue to support WVA in staging the Awards that help to put the spotlight on these critical issues addressed by our profession.”
Filming in the state of the art control room
We’ve just completed filming the amazing new NBIF (National Buried Infrastructure Facility) at University of Birmingham, which is unique in the world and led to a very cool Linked In posting by Nikolaos Venetsaneas, who is Business Engagement Manager at the University.
Just click on the logo below to see the post:
Here’s what they said about us:
World leading facility
Yesterday, we had the pleasure of recording a video with Good Call Media at the National Buried Infrastructure Facility (#NBIF_UK) to showcase the cutting-edge MTS Systems Corporation equipment and capabilities available within the facility.
(We even had the opportunity to unbox ‘Big Bertha’ : our
largest 200-tonne actuator!).🙂
The aim is to share our expertise, advanced technologies, and groundbreaking solutions globally with industry stakeholders and markets, giving NBIF unparalleled international reach and visibility.
Fiona filming on the moving floor
A big thanks to:
*Good Call Media team (Fiona Molloy, Nik Wood)
*MTS Systems Corporation team (Paul Hold, Paul Lehman, Garth Su PhD MBA)
* #NBIF_UK team (Nicole Metje, Asaad Faramarzi, Kieran Hansard, Christopher Harbutt, Ethan Ashton, Scott Hockell)
We say – “a big thanks Nik”.
We hosted Volition RX’s Capital Markets Day in the New York Stock Exchange.
Nik Wood hosted the video and the live event inside the Stock Exchange and Good Call Media co-owner, Fiona Molloy, was on camera for the session (which included a trip to the busy stock exchange trading floor) and also edited videos that were used in the presentations.
Volition is a multi-national epigenetics company powered by Nu.Q®, its proprietary nucleosome quantification platform. Through its subsidiaries, Volition is developing simple, easy to
https://youtu.be/QBvzhwCzc4Euse, cost effective blood tests to help diagnose and monitor a range of life-altering diseases including some cancers and diseases associated with NETosis such as sepsis and COVID-19. Early diagnosis and monitoring have the potential to not only prolong the life of patients
but also improve their quality of life. The tests are based on the science of Nucleosomics™, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid – an indication that disease is present.
Volition’s research and development activities are centered in Belgium, with an innovation laboratory and office in the U.S. and additional offices in London and Singapore.
Volition is a multi-national epigenetics company powered by Nu.Q®, its proprietary nucleosome quantification platform. Through its 
subsidiaries, Volition is developing simple, easy to use, cost effective blood tests to help diagnose and monitor a range of life-altering diseases including some cancers and diseases associated with NETosis such as sepsis and COVID-19. Early diagnosis and monitoring have the potential to not only prolong the life of patients but also improve their quality of life. The tests are based on the science of Nucleosomics™, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid – an indication that disease is present.
Volition’s research and development activities are centered in Belgium, with an innovation laboratory and office in the U.S. and additional offices in London and Singapore.